ADMA

ADMA BiologicsC

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-22

View Chart

Curated Events

Active

Recent Headlines

New

Curated events

Materiality

capital returnSentiment +72

Source

External coverage

Decided

2026-05-06

ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative

The payload identifies ADMA as the issuer and describes a large accelerated share repurchase plus a broader 2026 buyback plan, which is generally a positive capital-return signal for the stock.

View event details1 more curated

Sentiment decomposition

-0.2

30-day score

Company-55%

Macro-30%

Pulse-15%

The 30-day sentiment score is a decayed blend of Company, Macro, and Pulse components.

Recent headlines

No supplemental ticker headlines stored yet

We are still collecting relevant articles for ADMA. Curated events highlight the most material developments impacting this ticker right now.

Check curated events Open full news archive

As of 2026-05-06 • Updated scheduledSource: News desk